CHAPEL HILL, N.C., Aug. 5, 2016 /PRNewswire/ -- The last decade has seen an explosion in the availability of data that candeliver valuable insights for the pharmaceutical sector– from Electronic Medical Records and clinical trial data to medical claims and patient behavior information.
Pharma recognizes the huge potential that these large banks of data – more commonly
To inform these efforts and to probe current trends and best practices in utilizing big data, research and consulting leader Best Practices, LLC has published a new benchmarking study, "Analytics Excellence: Current and Future Trends for Big Data Utilization in Pharma."
The study, which has healthy amounts of both qualitative and quantitative data, addresses many issues that analytics leaders are wrestling with, including where to invest in their big data efforts.
Data management - data acquisition and infrastructure - represents about 60 percent of study participants' big data non-labor budget. It also is expected to make up most of the growth in future costs for companies as they expand their data capabilities and utilization of big data, according to the study. The average big data non-labor budget for all participants in the research project was just over $14 million.
The data in this study provides an opportunity for gaining actionable insights that goes beyond what's currently available via white papers or symposiums. The depth of insights extends across the critical components of pharma-oriented big data programs and include:
Best Practices, LLC engaged 22 leaders from 18 pharmaceutical companies through a benchmarking survey. Research analysts also conducted seven deep-dive executive interviews with selected benchmark participants.
To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1437.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/study-examines-big-data-presence-utilization-across-medical-and-commercial-operations-in-the-pharmaceutical-industry-300310028.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Noni is a traditional medicinal plant, also known as Indian mulberry. It has various health ...
Truncus arteriosus is a birth defect in which there is only one main artery in the heart that ...
Appendicitis in children produces symptoms of abdominal pain and swelling, nausea, vomiting and ...View All